Ares Financial Consulting’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$14.8K Sell
171
-16
-9% -$1.33K 0.01% 478
2026
Q2
$12.6K Buy
187
+21
+13% +$1.4K 0.01% 520
2026
Q1
$10.4K Buy
166
+50
+43% +$3.48K 0.01% 535
2025
Q4
$7.7K Buy
+116
New +$7.5K 0.01% 397

Other funds holding DXCM

Ares Financial Consulting's DXCM Position: Q3 2026 in Review

Ares Financial Consulting reduced its DexCom (DXCM) stake by 8.6% in Q3 2026, selling an estimated $1.33K and leaving 171 shares worth $14.8K. The position accounts for 0.01% of the portfolio, ranked #478.

Ares Financial Consulting first reported a position in DXCM in Q4 2025 and has held it in 4 quarters since. 944 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Ares Financial Consulting held 171 shares of DexCom worth $14.8K as of Q3 2026.
  • Ares Financial Consulting sold 16 DexCom shares in Q3 2026, an estimated $1.33K.
  • DexCom made up 0.01% of Ares Financial Consulting's portfolio in Q3 2026, its #478 holding.
  • Ares Financial Consulting first reported a position in DexCom in Q4 2025 and has held it in 4 quarters since.
  • 944 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.